FYERS
Godavari Drugs119.90
+0.80 (+0.67%)

Godavari Drugs Share Price

119.90+0.80 (+0.67%)
+43.40% past 1 Year

Corporate filings & documents

Announcements

Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 inter alia to consider and approve and take on record Un-audited Financial Results of the Company for the second quarter and half year ended September 30 2026
17 hours ago
The Board of Directors at its meeting held on 05.11.2026 approved the allotment of 7 86 690 Equity Shares to the Promoter Category on conversion of warrants upon receipt of the balance amount. Details are enclosed.
1 day ago
Please find enclosed herewith an intimation regarding change in Corporate Identification Number (CIN) of the company consequent upon alteration of the Object Clause of the Memorandum of Association.
3 weeks ago
Please find enclosed herewith an intimation regarding change in Corporate Identification Number (CIN) of the company consequent upon alteration of the Object Clause of the Memorandum of Association.
3 weeks ago
The Board of Directors of Godavari Drugs Limited at its meeting held on 14th October 2026 approved availing of Working Capital Limits up to Rs. 340 Million from ICICI Bank Limited and authorised the Managing Director to complete the necessary formalities. The outcome is enclosed.
3 weeks ago
The Board of Directors of Godavari Drugs Limited at its meeting held on 14th October 2026 approved availing of Working Capital Limits up to Rs. 340 Million from ICICI Bank Limited and authorised the Managing Director to complete the necessary formalities. The outcome is enclosed.
3 weeks ago
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended September 30 2026
3 weeks ago
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended September 30 2026
3 weeks ago
Voting Results & Scrutinizer Report of 38th Annual General Meeting of Godavari Drugs Limited
1 month ago
Voting Results & Scrutinizer Report of 38th Annual General Meeting of Godavari Drugs Limited
1 month ago
Proceedings of the 38th AGM held on 25.09.2026
1 month ago
Proceedings of the 38th AGM held on 25.09.2026
1 month ago
Intimation of Closure of Trading Window with effect from 1st October 2026 for the purpose of consideration and approval of the unaudited Financials for the quarter and half year ended 30th September 2026
1 month ago
Intimation of Closure of Trading Window with effect from 1st October 2026 for the purpose of consideration and approval of the unaudited Financials for the quarter and half year ended 30th September 2026
1 month ago
We hereby inform that the company has dispatched a physical letter to the shareholders whose email addresses are not registered with the company/RTA/Depositories/DP. The Letter contains details to access the notice and Annual Report for the Financial year 2025-26 on the companys Website
2 months ago
We hereby inform that the company has dispatched a physical letter to the shareholders whose email addresses are not registered with the company/RTA/Depositories/DP. The Letter contains details to access the notice and Annual Report for the Financial year 2025-26 on the companys Website
2 months ago
Newspaper Publication for the 38th Annual General Meeting and E-Voting Instructions
2 months ago
Newspaper Publication for the 38th Annual General Meeting and E-Voting Instructions
2 months ago
The Company informed that the 38th AGM of the Company is scheduled to be held on Friday the 25th Sep 2026 at 03.00 pm through Video Conferencing/ other Audio Visual means in accordance with Circulars issued by the MCA and SEBI. The Annual Report containing 38th AGM is also uploaded on the Companies Website and the same shall also be available on the website of NSDL.
2 months ago
The Company informed that the 38th AGM of the Company is scheduled to be held on Friday the 25th Sep 2026 at 03.00 pm through Video Conferencing/ other Audio Visual means in accordance with Circulars issued by the MCA and SEBI. The Annual Report containing 38th AGM is also uploaded on the Companies Website and the same shall also be available on the website of NSDL.
2 months ago
Notice of 38th AGM to be held on 25th Sep 2026 at 03.00 p.m. through Video Conferencing/Other Audio Visual Means in accordance with the relevant circulars issued by the MCA and SEBI.
2 months ago
Notice of 38th AGM to be held on 25th Sep 2026 at 03.00 p.m. through Video Conferencing/Other Audio Visual Means in accordance with the relevant circulars issued by the MCA and SEBI.
2 months ago
The Register of Members and Share Transfer Books of the Company will remain closed from 19.09.2026 to 25.09.2026 (Both days Inclusive) for taking record of the Members of the Company for the purpose of 38th AGM to be held on 25.09.2026 at 03.00 p.m. Cut off date - 18.09.2026 Evoting Period 22.09.2026 to 24.09.2026 Evoting time 9.00 a.m. End 5.00 p.m
2 months ago
The Register of Members and Share Transfer Books of the Company will remain closed from 19.09.2026 to 25.09.2026 (Both days Inclusive) for taking record of the Members of the Company for the purpose of 38th AGM to be held on 25.09.2026 at 03.00 p.m. Cut off date - 18.09.2026 Evoting Period 22.09.2026 to 24.09.2026 Evoting time 9.00 a.m. End 5.00 p.m
2 months ago
Amendment to MOA of the company was approved by Board of Directors. The Proposed change in MOA of the company is subject to necessary approvals from Ministry of Corporate Affairs Shareholders in a 38th Annual General Meeting and any other regulatory authority and consequent amendments to the Memorandum of Association of the Company will be done.
2 months ago
Amendment to MOA of the company was approved by Board of Directors. The Proposed change in MOA of the company is subject to necessary approvals from Ministry of Corporate Affairs Shareholders in a 38th Annual General Meeting and any other regulatory authority and consequent amendments to the Memorandum of Association of the Company will be done.
2 months ago
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we inform that the Board of Directors at its meeting held on 31st August 2026 approved the following:1. Alteration of the Main Objects Clause III(A) of the Memorandum of Association by inserting a new Main Object No. 4 relating to nutraceuticals natural extracts and food ingredients subject to approval of Members by Special Resolution at the ensuing 38th Annual General Meeting.2. Revised Notice of the 38th Annual General Meeting to be held on 25th September 2026.
2 months ago
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we inform that the Board of Directors at its meeting held on 31st August 2026 approved the following:1. Alteration of the Main Objects Clause III(A) of the Memorandum of Association by inserting a new Main Object No. 4 relating to nutraceuticals natural extracts and food ingredients subject to approval of Members by Special Resolution at the ensuing 38th Annual General Meeting.2. Revised Notice of the 38th Annual General Meeting to be held on 25th September 2026.
2 months ago
Submission of Statement on Deviation or Variation in uitilisation of Funds for the quarter ended 30 june 2026
2 months ago
Submission of Statement on Deviation or Variation in uitilisation of Funds for the quarter ended 30 june 2026
2 months ago
Newspaper Publication of Unaudited Results for quarter ended 30.06.2026
2 months ago
Newspaper Publication of Unaudited Results for quarter ended 30.06.2026
2 months ago
Board of Directors of the Company in its meeting held on Friday 14th August 2026 at 11.45 A.M. approved and passed the resolution for allotment of Equity Shares on conversion of 7 86 690 Equity Shares at an issue price of Rs.89/- each to Promoters Category on Preferential Basis
2 months ago
Board of Directors of the Company in its meeting held on Friday 14th August 2026 at 11.45 A.M. approved and passed the resolution for allotment of Equity Shares on conversion of 7 86 690 Equity Shares at an issue price of Rs.89/- each to Promoters Category on Preferential Basis
2 months ago
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30 2026
2 months ago
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30 2026
2 months ago
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30 2026 and Allotment of Equity Shares on conversion of 7 86 690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) warrants into 7 86 690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) Equity Shares at an issue price of Rs. 89/- each (including a premium of Rs. 10/- each) to Promoters Category on preferential basis
2 months ago
Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30 2026 and Allotment of Equity Shares on conversion of 7 86 690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) warrants into 7 86 690 (Seven Lakhs Eighty-Six Thousand Six Hundred and Ninety Only) Equity Shares at an issue price of Rs. 89/- each (including a premium of Rs. 10/- each) to Promoters Category on preferential basis
2 months ago
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Update on board meeting - Intimation of the Board Meeting of Godavari Drugs Limited (the Company) to be held on Friday August 14th 2026
2 months ago
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Update on board meeting - Intimation of the Board Meeting of Godavari Drugs Limited (the Company) to be held on Friday August 14th 2026
2 months ago
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the Quarter ended June 30 2026.
2 months ago
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Un-audited Financial Results of the Company for the Quarter ended June 30 2026.
2 months ago
Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018
3 months ago
Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018
3 months ago
Intimation of Closure of Trading window for the quarter ended June 30 2026
4 months ago
Intimation of Closure of Trading window for the quarter ended June 30 2026
4 months ago
Please find the enclosed newspaper publication for your information
5 months ago
Refer Enclosed
5 months ago
Company in its Board Meeting has approved financial results for period ended 31st march 2026
5 months ago
Company in its Board Meeting has approved financial results for period ended 31st march 2026
5 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Godavari Drugs Ltd Share Price Today

The Godavari Drugs Ltd share price today is ₹118.1. During the trading session, the Godavari Drugs Ltd share price opened at ₹121 and recorded an intraday high of ₹127.5 and a low of ₹116.8. Last closing price was ₹120.62. Over the past 52 weeks, the Godavari Drugs Ltd share price has ranged between ₹69.7 and ₹135.25. The current Godavari Drugs Ltd stock price reflects real-time market activity based on executed trades on the exchange.